No registrations found.
ID
Source
Brief title
Health condition
COVID 19
Sponsors and support
Intervention
Outcome measures
Primary outcome
1. Number of necessities to transfer from regular ward to IC department
2. Mortality rate
Secondary outcome
1. Number of days admitted
2. Number of days before reaching primary outcome
Background summary
The study aims to investigate whether suppletion of iodine in patients with COVID-19 disease has a preventive effect on deterioration of symptoms.
Study objective
Treatment with oral iodine prevents deterioration of symptoms in COVID-19 patients admitted to a hospital.
Study design
Inclusion from 23rd of October 2020 till the first of July 2022
Patients will be followed until discharge from the hospital or dead in hospital.
Intervention
Once daily a quarter of a 65 mg potassiumiodine tablet during eight consecutive days
Inclusion criteria
Patients 18 years of age and older, admitted to a hospital and who are tested positive for SARS-CoV-2 infection, are recruited for the study.
Patiënts must be legally competent and able to read the patient's information letter and sign the informed consent form.
Exclusion criteria
Thyroid disease or treatment, like goiter, thyroidectomy, radioactive iodine, medication related to thyroid dysfunction or the use of Amiodaron.
Design
Recruitment
IPD sharing statement
Followed up by the following (possibly more current) registration
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL9161 |
| CCMO | NL73784.028.20 |
| OMON | NL-OMON49526 |